Postmenopausal hormone therapy offers no protection against heart attacks

American Medical Association

American Medical Association.

Ginecol. obstet. Méx ; 70(8): 404-405, Aug. 2002.

Article in English | LILACS | ID: lil-331060

Subject(s)

Aged; Female; Humans; Middle Aged; Hormone Replacement Therapy; Myocardial Infarction/prevention & control; Controlled Clinical Trials as Topic; Coronary Disease; Gallbladder Diseases/epidemiology; Gallbladder Diseases/surgery; Double-Blind Method; Drug Combinations; Randomized Controlled Trials as Topic; Estrogens/administration & dosage; Estrogens, Conjugated (USP); Follow-Up Studies; Medroxyprogesterone Acetate; Placebos; Postmenopause; Progestins; Risk Factors; Hormone Replacement Therapy/adverse effects; Thrombosis; Time Factors

Search on Google

XML

Index: LILACS (Americas) Main subject: Hormone Replacement Therapy / Myocardial Infarction Type of study: Controlled clinical trial / Etiology study / Observational study / Prognostic study / Risk factors Limits: Aged / Female / Humans Language: English Journal: Ginecol. obstet. Méx Journal subject: Gynecology / Obstetrics Year: 2002 Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML